Thomas Stevens
Directeur/Membre du Conseil chez BioFlorida, Inc.
Profil
Thomas Stevens has been President of Bio-America, Inc. since May 2004.
He received an undergraduate degree from Trent University and an MBA from the University of Toronto.
Postes actifs de Thomas Stevens
| Sociétés | Poste | Début |
|---|---|---|
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Directeur/Membre du Conseil | 28/04/2009 |
Anciens postes connus de Thomas Stevens
| Sociétés | Poste | Fin |
|---|---|---|
| BIO AMERICA INC | President | - |
Formation de Thomas Stevens
| Trent University | Undergraduate Degree |
| University of Toronto | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bio-America, Inc.
 Bio-America, Inc. Pharmaceuticals: MajorHealth Technology Bio-America, Inc. is a biotechnology company. It researches and develops drug-screening technologies for manufacturing anti-obesity, anti-infective and oncology products. The company was founded in 1999 and is headquartered in Toronto, CA. | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |
